Type 2 diabetes. Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: According to a physician's diagnosis, they have more than one year of type 2 Diabetes Have a low mobility Use only Glucose-lowering drugs (Metformin)
Exclusion criteria
Exclusion criteria: Have be Secondary complications of diabetes, such as ocular, kidney complications Have be cardiovascular and inflammatory diseases Have a physical injury
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fibroblast growth factor 21. Timepoint: Blood samples were taken at once in the first stage(pre-test) and secondly(post-test) after 8 weeks of exercise. Method of measurement: Fibroblast growth factor factor 21 kit.;Insulin resistance. Timepoint: Blood samples were taken once in the first stage(pre-test) and the second time(post-test) after 8 weeks of training. Method of measurement: Formula for evaluation of insulin resistance homeostasis model(HOMA-IR). | — |
Secondary
| Measure | Time frame |
|---|---|
| Glucose. Timepoint: Blood samples were taken once in the first stage (pre-test) and the second time (post-test) after 8 weeks of training. Method of measurement: Glucose Kit and Colorimetric Enzymatic Method.;Insulin. Timepoint: Blood samples were taken once in the first stage (pre-test) and the second time (post-test) after 8 weeks of training. Method of measurement: Insulin kit and Elisa method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahroud University of Medical Sciences